The Ezetimibe Market is poised for steady expansion as the global Healthcare industry continues to witness rising demand for lipid-lowering therapies to manage cardiovascular diseases and hypercholesterolemia. According to Future Market Insights (FMI), the market is projected to grow from USD 19.7 million in 2026 to USD 33.4 million by 2036, registering a 5.4% CAGR during the forecast period....